Home / Stocks / CHRO

CHRO insider trading

Chromocell Therapeutics Corp — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$26k
Buys · last 90 days
0 · $0
Most recent buy
2024-09-16

Recent insider filings

FiledInsiderTypeSharesPriceValue
2024-09-16Malamut Richard
Director
Bought10,400$0.94$10k
2024-09-16Francis Knuettel II
CEO, Pres., CFO, Treas & Secty
Bought5,200$0.97$5k
2024-09-12Francis Knuettel II
CEO, Pres., CFO, Treas & Secty
Bought12,000$0.91$11k

Most active insider buyers

InsiderRoleBuysTotal bought
Francis Knuettel IICEO, Pres., CFO, Treas & Secty2$16k
Malamut RichardDirector1$10k

See CHRO on the chart

Every insider buy and sell for CHRO plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.